LASSA FEVER
Clinical trials for LASSA FEVER explained in plain language.
Never miss a new study
Get alerted when new LASSA FEVER trials appear
Sign up with your email to follow new studies for LASSA FEVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New oral drug shows promise in fight against deadly lassa fever
Disease control Recruiting nowThis study tests a new oral antiviral drug, ARN-75039, for treating Lassa fever in hospitalized adults in West Africa. About 135 participants will receive either a high or low dose of the new drug or the standard IV treatment, ribavirin. The goal is to see if the new drug is safe…
Matched conditions: LASSA FEVER
Phase: PHASE2 • Sponsor: Arisan Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
Race to save lives: new drug trial targets deadly lassa fever in west africa
Disease control Recruiting nowThis large clinical trial is testing new or repurposed drugs to treat Lassa fever, a viral illness that kills thousands each year in West Africa. The study will enroll about 1,755 hospitalized patients across several countries to see if these drugs can reduce deaths and prevent s…
Matched conditions: LASSA FEVER
Phase: PHASE2, PHASE3 • Sponsor: Irrua Specialist Teaching Hospital • Aim: Disease control
Last updated May 22, 2026 14:05 UTC